LSPW
DNA icon

Lake Street Private Wealth’s Ginkgo Bioworks DNA Stock Holding History

Lake Street Private Wealth’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-766
Closed -$10.2K – 275
2024
Q2 		$10.2K Hold
766
– – ﹤0.01% 320
2024
Q1 		$35.5K Buy
766
+515
+205% +$26.7K ﹤0.01% 313
2023
Q4 		$17K Hold
251
– – ﹤0.01% 301
2023
Q3 		$17.3K Hold
251
– – ﹤0.01% 281
2023
Q2 		$18.7K Hold
251
– – ﹤0.01% 284
2023
Q1 		$13.4K Hold
251
– – ﹤0.01% 284
2022
Q4 		$16.8K Buy
251
+1
+0.4% +$92 ﹤0.01% 277
2022
Q3 		$31K Buy
+250
New +$29.8K 0.01% 271

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return